Caffeine for treatment of Parkinson disease: A randomized controlled trial

OBJECTIVE: Epidemiologic studies consistently link caffeine, a nonselective adenosine antagonist, to lower risk of Parkinson disease (PD). However, the symptomatic effects of caffeine in PD have not been adequately evaluated. METHODS: We conducted a 6-week randomized controlled trial of caffeine in...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Postuma, Ronald B., Lang, Anthony E., Munhoz, Renato P., Charland, Katia, Pelletier, Amelie, Moscovich, Mariana, Filla, Luciane, Zanatta, Debora, Rios Romenets, Silvia, Altman, Robert, Chuang, Rosa, Shah, Binit
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2012
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3414662/
https://ncbi.nlm.nih.gov/pubmed/22855866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e318263570d
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki